Journal article
The Emerging Drugs Network of Australia – Victoria Clinical Registry: A state-wide illicit substance surveillance and alert network
R Syrjanen, J Schumann, J Fitzgerald, D Gerostamoulos, R Abouchedid, JA Rotella, J Knott, J Maplesden, H Hollerer, L Hannon, E Bourke, SE Hodgson, SL Greene
EMA Emergency Medicine Australasia | Published : 2023
Abstract
Objectives: With an increasingly dynamic global illicit drug market, including the emergence of novel psychoactive substances, many jurisdictions have moved to establish toxicosurveillance systems to enable timely detection of harmful substances in the community. This paper describes the methodology for the Emerging Drugs Network of Australia – Victoria (EDNAV) project, a clinical registry focused on the collection of high-quality clinical and analytical data from ED presentations involving illicit drug intoxications. Drug intelligence collected from the project is utilised by local health authorities with the aim to identify patterns of drug use and emerging drugs of concern. Methods: The p..
View full abstractGrants
Funding Acknowledgements
The Emerging Drugs Network of Australia -Victoria project site investigators: Professor Andis Graudins, Monash Health, Victoria, Australia; Dr Hweemin Lee, Monash Health, Victoria, Australia; Ms Angela Dean, Melbourne Health, Victoria, Australia; Dr Siba Sulaeman, Peninsula Health, Victoria, Australia. The Victorian Institute of Forensic Medicine: Mr Matthew Di Rago, Victorian Institute of Forensic Medicine, Victoria, Australia; Ms Samantha Joubert, Victorian Institute of Forensic Medicine, Victoria, Australia; Dr Jared Castle, Victorian Institute of Forensic Medicine, Victoria, Australia. The EDNAV project acknowledges funding provided by the Department of Health (Victorian State Government) and the Emerging Drugs Network of Australia (EDNA).